1. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy. Issue 11 (10th July 2021) Authors: Bazinet, Michel; Anderson, Mark; Pântea, Victor; Placinta, Gheorghe; Moscalu, Iurie; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Iarovoi, Liviu; Smesnoi, Valentina; Musteata, Tatina; Jucov, Alina; Dittmer, Ulf; Gersch, Jeff; Holzmayer, Vera; Kuhns, Mary; Cloherty, Gavin; Vaillant, An... Journal: Hepatology communications Issue: Volume 5:Issue 11(2021) Page Start: 1873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benefit of transaminase elevations in establishing functional cure of HBV infection during nap‐based combination therapy. Issue 5 (26th February 2021) Authors: Bazinet, Michel; Pântea, Victor; Placinta, Gheorghe; Moscalu, Iurie; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Iarovoi, Liviu; Smesnoi, Valentina; Musteata, Tatiana; Jucov, Alina; Dittmer, Ulf; Krawczyk, Adalbert; Vaillant, Andrew Journal: Journal of viral hepatitis Issue: Volume 28:Issue 5(2021) Page Start: 817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection. Issue 8 (2nd April 2022) Authors: Bazinet, Michel; Anderson, Mark; Pântea, Victor; Placinta, Gheorghe; Moscalu, Iurie; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Iarovoi, Liviu; Smesnoi, Valentina; Musteata, Tatina; Jucov, Alina; Dittmer, Ulf; Gersch, Jeff; Holzmayer, Vera; Kuhns, Mary; Cloherty, Gavin; Vaillant, An... Journal: Hepatology communications Issue: Volume 6:Issue 8(2022) Page Start: 1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Kinetics of hepatitis B surface antigen quasispecies during REP 2139‐Ca therapy in HBeAg‐positive chronic HBV infection. Issue 12 (13th August 2019) Authors: Usman, Zainab; Mijočević, Hrvoje; Karimzadeh, Hadi; Däumer, Martin; Al‐Mathab, Mamun; Bazinet, Michel; Frishman, Dmitrij; Vaillant, Andrew; Roggendorf, Michael Journal: Journal of viral hepatitis Issue: Volume 26:Issue 12(2019) Page Start: 1454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Letter to the Editor: Examining HBV‐RNA Kinetics During NA Treatment—Are NAs Multifunctional Antiviral Agents?. Issue 3 (3rd June 2021) Authors: Dahari, Harel; Vaillant, Andrew; Cotler, Scott J. Journal: Hepatology Issue: Volume 74:Issue 3(2021) Page Start: 1708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Letter to the Editor: Is the HBsAg response to RO7062931 an antisense effect?. Issue 1 (27th November 2021) Authors: Vaillant, Andrew Journal: Hepatology Issue: Volume 75:Issue 1(2022) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks. Issue 6 (23rd February 2018) Authors: Quinet, Jonathan; Jamard, Catherine; Burtin, Madeleine; Lemasson, Matthieu; Guerret, Sylviane; Sureau, Camille; Vaillant, Andrew; Cova, Lucyna Journal: Hepatology Issue: Volume 67:Issue 6(2018) Page Start: 2127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection. Issue 2 (13th November 2020) Authors: Bazinet, Michel; Pântea, Victor; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Anderson, Mark; Gersch, Jeff; Holzmayer, Vera; Elsner, Carina; Krawczyk, Adalbert; Kuhns, Mary C.; Cloherty, Gavin; Dittmer, Ulf; Vaillant, Andrew Journal: Hepatology communications Issue: Volume 5:Issue 2(2021) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. (December 2017) Authors: Bazinet, Michel; Pântea, Victor; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Albrecht, Jeffrey; Schmid, Peter; Le Gal, Frédéric; Gordien, Emmanuel; Krawczyk, Adalbert; Mijočević, Hrvoje; Karimzadeh, Hadi; Roggendorf, Michael; Vaillant, Andrew Journal: Lancet gastroenterology and hepatology Issue: Volume 2:Number 12(2017) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?. Issue 3 (March 2019) Authors: Vaillant, Andrew Journal: Lancet infectious diseases Issue: Volume 19:Issue 3(2019) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗